Fellow NWBO Investors,
I've been an investor in NWBO since last spring so not near as long as many of you. I feel your pain though as a 11 year Investor of Amarin.
Ive been in the pharmaceutical industry for over 30 years now so I have a good idea how the regulatory, sales and marketing areas of this industry works. I'm not a legal expert.
I understand many of your frustrations recently with NWBO's Senior Management and their lack of communication.
I had a 30-45 minute long conversation with their investor relations person today. I expressed many of your concerns and allowed him to share the reasons why there has not been much, if any, communication over the past 60 days. Everything he shared with me is 100 percent in line with my experience over the past 30 years in this industry in various high-level positions. Yes they are in a quiet period as it relates to financials and regulatory topics and questions. Reason because they are in deep and high-level discussion with the FDA and other significant stakeholders.
Bottom line there is absolutely nothing right this second that would be material that they could announce or communicate with us the investors. It was crystal clear from my conversation and I agree this should under no circumstance be perceived or taken as negative. They are working tirelessly with both regulatory agencies,KOL's, Advisors, Experts and top peer reviewed medical journals to finalize the announcement of TLD.
For those who believe everything you read from scumbags like Adam FartStain it's time to wake up and ignore losers like that SOB.
LP announced at a small charity event back in early October they would be locking the data and then it would be sent to the statisticians. Adam FartStain reported back in September NWBO had already been unblinded to the data and new it was not good. The company cannot be unblinded until the data is locked and it goes to the statisticians. This is why he's a scumbag and misleads uninformed investors.
I honestly believe NWBO is real close to releasing TLD along with which prestigious and credible peer review journal will be publishing the results. This takes a lot of time especially in the virtual world we are navigating through currently. Their IR Guy told me today there are so many moving parts going on right now and the last thing Senior Management would want to do is send a communication on something that potentially would screw it up for them after all of these years. He basically said right now there is nothing new they could communicate to their investors. I mentioned many of you on these message boards are struggling with the lack of communication and updates. While they are sensitive to that they realize they are so close after all of these years to achieving major milestones and hundreds of millions dollars they invested in clinical trials have chosen to wait until they have everything ready to go and meaningful information to share with us. Also he mention the silence and lack of communication should not be perceived or taken as negative that they know the data is bad or the financials are a mess etc.
So as a fellow investor my suggestion is if you invested in NWBO because of the science as I definitely did be patient and let the review of the science take us to the finish line.
The Best is Yet to Come.
